Richard Buchta
Director/Miembro de la Junta en BERONI GROUP LIMITED .
Cargos activos de Richard Buchta
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BERONI GROUP LIMITED | Director/Miembro de la Junta | 01/07/2020 | - |
Independent Dir/Board Member | 01/07/2020 | - | |
Formulytica Pty Ltd.
Formulytica Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Opal Biosciences Ltd., Formulytica Pty Ltd. is a specialty research organization that provides regulatory solutions, training in formulation and analytical techniques, and troubleshooting formulation and analytical methods. The company is based in Mulgrave, Australia. The Australian company specializes in contract formulation development services, analytical method development and validation, new product development, and the analytical science of semi-solid formulations. Formulytica was acquired by Opal Biosciences Ltd. on May 05, 2021. | Director/Miembro de la Junta | - | - |
Opal Biosciences Ltd.
Opal Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Opal Biosciences Ltd. develops antimicrobial and anti-infective products. The company was founded in and is headquartered in South Melbourne, Australia. | Director/Miembro de la Junta | 05/05/2021 | - |
Historial de carrera de Richard Buchta
Antiguos cargos conocidos de Richard Buchta.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Vyome Therapeutics, Inc.
Vyome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vyome Therapeutics, Inc. develops research-based dermatology pharmaceutical solutions. It also develops drugs for antibiotics-resistant acne and other pathogens through a pipeline of antibiotics that retard resistance development. The company was founded by Rajesh Sudhir Gokhale, Rajeev Mantri, Venkateswarlu Nelabhotla, and Shiladitya Sengupta in August 2010 and is headquartered in Princeton, NJ. | Director Técnico/Científico/I+D | 01/12/2014 | - |
Formación de Richard Buchta.
Monash University | Undergraduate Degree |
Deakin University | Masters Business Admin |
Weizmann Institute of Science | Doctorate Degree |
University of Trieste | Doctorate Degree |
Estadísticas
Internacional
Australia | 6 |
Estados Unidos | 2 |
Israel | 2 |
Operativa
Director/Board Member | 3 |
Doctorate Degree | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Consumer Services | 5 |
Health Technology | 4 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BERONI GROUP LIMITED | Health Technology |
Empresas privadas | 3 |
---|---|
Vyome Therapeutics, Inc.
Vyome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vyome Therapeutics, Inc. develops research-based dermatology pharmaceutical solutions. It also develops drugs for antibiotics-resistant acne and other pathogens through a pipeline of antibiotics that retard resistance development. The company was founded by Rajesh Sudhir Gokhale, Rajeev Mantri, Venkateswarlu Nelabhotla, and Shiladitya Sengupta in August 2010 and is headquartered in Princeton, NJ. | Health Technology |
Formulytica Pty Ltd.
Formulytica Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Opal Biosciences Ltd., Formulytica Pty Ltd. is a specialty research organization that provides regulatory solutions, training in formulation and analytical techniques, and troubleshooting formulation and analytical methods. The company is based in Mulgrave, Australia. The Australian company specializes in contract formulation development services, analytical method development and validation, new product development, and the analytical science of semi-solid formulations. Formulytica was acquired by Opal Biosciences Ltd. on May 05, 2021. | Commercial Services |
Opal Biosciences Ltd.
Opal Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Opal Biosciences Ltd. develops antimicrobial and anti-infective products. The company was founded in and is headquartered in South Melbourne, Australia. | Health Technology |
- Bolsa de valores
- Insiders
- Richard Buchta
- Experiencia